404 related articles for article (PubMed ID: 16319528)
1. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
[TBL] [Abstract][Full Text] [Related]
2. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro.
Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447
[TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo.
Lu S; Huang Q; Wang Z; Song Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):620-4. PubMed ID: 19821097
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
6. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance.
Lage H
Curr Drug Targets; 2006 Jul; 7(7):813-21. PubMed ID: 16842213
[TBL] [Abstract][Full Text] [Related]
7. Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line.
Dong Y; Shao S; Hu J; Yang P
Oral Oncol; 2009 Nov; 45(11):991-7. PubMed ID: 19631573
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
10. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
11. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
Chen XP; Wang Q; Guan J; Huang ZY; Zhang WG; Zhang BX
World J Gastroenterol; 2006 Jun; 12(21):3332-7. PubMed ID: 16733848
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
Chen LM; Liang YJ; Zhang X; Su XD; Dai CL; Wang FP; Yan YY; Tao LY; Fu LW
Anticancer Res; 2009 Nov; 29(11):4597-604. PubMed ID: 20032409
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
14. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
Stege A; Priebsch A; Nieth C; Lage H
Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells.
He Y; Bi Y; Hua Y; Liu D; Wen S; Wang Q; Li M; Zhu J; Lin T; He D; Li X; Wang Z; Wei G
J Exp Clin Cancer Res; 2011 Oct; 30(1):104. PubMed ID: 22035293
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
17. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
[TBL] [Abstract][Full Text] [Related]
18. [Reversion of multidrug resistance (MDR) in human glioma cells by RNA interference (RNAi)].
Zhao P; Hu W; Zhang YZ; Sun MZ; He Y
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):183-7. PubMed ID: 16875601
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
[TBL] [Abstract][Full Text] [Related]
20. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.
Sheng L; Xiong M; Li C; Meng X
Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
